Abstract:BACKGROUND:MicroRNAs (miRNAs) exhibit essential regulatory functions related to cell growth, apoptosis, development and differentiation. Dysregulated expression of miRNAs is associated with a wide variety of human diseases. As such miRNA signatures are valuable as biomarkers for disease and for making treatment decisions. Hepatitis B virus (HBV) is a major risk factor for hepatocellular carcinoma (HCC). Here we screened for miRNAs in chronic HBV associated HCC.METHODS:To determine the miRNAs in HCC occurrence associated with HBV infection, we analyzed global miRNA expression profiles in 12 pairs of HCC and adjacent matched non-HCC tissues from HBV-positive and HBV-negative patients using microarray analyses. The microarray result was validated by real-time PCR in 32 HBV-positive and 24 HBV-negative patient HCC samples. The potential candidate target genes of the miRNAs were predicted by miRWalk software. Genes simultaneously predicted as targets by two or more miRNAs were subjected to GO and KEGG pathway analysis. The miRNA regulatory network analysis was performed using the Ingenuity Pathway Analysis (IPA) software.RESULTS:Eight miRNAs (miR-223, miR-98, miR-15b, miR-199a-5p, miR-19b, miR-22, miR-451, and miR-101) were involved in HBV-unrelated HCC, 5 miRNAs (miR-98, miR-375, miR-335, miR-199a-5p, and miR-22) were involved in HBV infection, and 7 miRNAs (miR-150, miR-342-3p, miR-663, miR-20b, miR-92a-3p, miR-376c-3p and miR-92b) were specifically altered in HBV-related HCC. Gene Ontology and KEGG analyses predict that these HBV-related HCC miRNAs are involved in the regulation of: transcription, RNA polymerase II promoter, phosphorylation of proteins through MAPK signaling pathway, focal adhesion, and actin cytoskeleton. IPA analysis also suggest that these miRNAs act on AGO2, TP53, CCND1, and 11 other genes that significantly influence HCC occurrence and HBV infection.CONCLUSION:Our data indicates that the unique 7 miRNAs expression signature could be involved in the development HBV- related HCC.

miRNAs and human immunodeficiency virus type 1 infection:biomarkers and antiviral therapy

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

Microrna-155 is A Biomarker of T-Cell Activation and Immune Dysfunction in Hiv-1-Infected Patients

Biological function of microRNA in HIV-1 infection:summary of recent progress

Progress of the Stady on Microrna in Regulating Innate Immunity

The Role of MicroRNAs in HIV Infection

The impact of microRNAs on human immunodeficiency virus infection: A flying bullet to invader?

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

New Potential MicroRNA Biomarkers in Human Immunodeficiency Virus Elite Controllers, Human Immunodeficiency Virus Infections, and Coinfections with Hepatitis B Virus or Hepatitis C Virus

Human and Viral microRNA Expression in Acute and Chronic HIV Infections

MicroRNAs and exosomes: key players in HIV pathogenesis

MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Two Cellular Micrornas, Mir-196B and Mir-1290, Contribute to HIV-1 Latency

siRNA, miRNA and HIV: promises and challenges

Micrornas Are Biomarkers of Oncogenic Human Papillomavirus Infections

MicroRNAs may solve the mystery of chronic hepatitis B virus infection.

Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations

[HIV-1 Infection Changes Mirna Expression Profile in the Whole Blood].

Hsa-Mir-181-5p Inhibits Human Immunodeficiency Virus Type 1 Replication by Downregulating DDX3X Expression.